Palantir's NHS Data Contract Faces Growing Scrutiny Ahead of 2027 Break Point

NHS England officials are actively considering whether to end Palantir's Federated Data Platform contract at a 2027 break point, as concerns over trust, governance, and patient-data access intensify among politicians, campaigners, and health-system leaders.

The Details

NHS England's Federated Data Platform (FDP) contract, awarded in November 2023 to a consortium led by Palantir, began in March 2024 and runs on an initial three-year term through March 2027, with a possible extension to March 2031, according to an NHS England contract explainer.

An Al Jazeera report on May 12, 2026, said NHS England officials were openly weighing a 2027 break for the Palantir contract amid growing trust and governance concerns. The same report cited the Financial Times as saying an internal NHS England briefing note indicated Palantir employees had been allowed "unlimited" access to patient data, triggering renewed scrutiny. The Financial Times claim was not directly reviewed by Zero Signal News and is reported here via Al Jazeera.

Labour MP Emily Darlington told BBC News on April 14, 2026, that Palantir's involvement with NHS patient data is "a major security risk." She added: "The NHS is the biggest health service in the world with the biggest amount of patient data... It's a major security risk if you're working with a company whose chief executive talks about the NHS as a 'delusion' and doesn't share the values of the NHS or Britain in general." Multiple MPs have demanded more scrutiny of the company's use of NHS data, according to the BBC report.

Eerke Boiten, a cybersecurity professor at De Montfort University, told Al Jazeera that concerns extend beyond technical security. "Palantir's political leanings, expressed in their rhetoric, make them a potential security risk," he said.

A Palantir spokesperson told The Guardian that the company's software "is playing an important role in improving patient care – helping to deliver 100,000 additional operations, a 12% reduction in discharge delays and the removal of 675,000 patients from waiting lists."

NHS England says every trust and integrated care board has its own instance of the platform and complete control over access, and Palantir says it acts only as a data processor under NHS instruction and does not use NHS data for its own purposes.

Context

Palantir first entered the NHS during the COVID-19 pandemic with a nominal contract before expanding into the current Federated Data Platform relationship, which Al Jazeera reported is now worth hundreds of millions of pounds.

Health advocacy group Medact warned in a March 12, 2026 Guardian report that Palantir's NHS platform could enable future cross-departmental data sharing abuses if laws were to change. Greater Manchester's integrated care board deferred adopting the FDP over concerns about value for money and public trust risks, The Guardian reported.

Campaign groups including Good Law Project, Privacy International, and Medact have spent months pushing for more disclosure, warning that public trust in health data governance could erode if Palantir remains embedded in the NHS, according to Al Jazeera.

What's Next

No contract-termination decision has been announced, and current reporting indicates active consideration ahead of the March 2027 break point. With the initial committed term expiring in a year, NHS England and government ministers face a live decision about whether to renew, renegotiate, or end the Palantir partnership.

Greater Manchester's deferred adoption and Medact's warnings about future legal changes suggest the debate will continue to intersect with procurement policy, data-protection law, and regional trust-level governance. Whether NHS England can secure wider institutional buy-in before March 2027 remains unresolved.